Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-18-001247
Filing Date
2018-02-02
Accepted
2018-02-02 17:34:33
Documents
1
Period of Report
2018-01-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f4013118nkidronnadav_oramed.html 4  
1 OWNERSHIP DOCUMENT f4013118nkidronnadav_oramed.xml 4 3907
  Complete submission text file 0001213900-18-001247.txt   5512
Mailing Address HI-TECH PARK 2/4 GIVAT-RAM PO BOX 39098 JERUSALEM L3 91390
Business Address HI-TECH PARK 2/4 GIVAT-RAM PO BOX 39098 JERUSALEM L3 91390 011 972-2-566-0001
ORAMED PHARMACEUTICALS INC. (Issuer) CIK: 0001176309 (see all company filings)

EIN.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2 ELZA STREET JERUSALEM L3 93706
Business Address
KIDRON NADAV (Reporting) CIK: 0001351779 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35813 | Film No.: 18572071